Analgesic Clinical Trials Innovations, Opportunities, and Networks (ACTION)

The summary for the Analgesic Clinical Trials Innovations, Opportunities, and Networks (ACTION) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Food and Drug Administration, which is the U.S. government agency offering this grant.
Analgesic Clinical Trials Innovations, Opportunities, and Networks (ACTION): This award is intended to provide support for developing and maintaining an organizational infrastructure to support a broad-based public-private partnership under FDA's Analgesic Clinical Trials Innovations, Opportunities, and Networks (ACTION) Initiative. Specific projects under the ACTION Initiative may also be funded.
Federal Grant Title: Analgesic Clinical Trials Innovations, Opportunities, and Networks (ACTION)
Federal Agency Name: Food and Drug Administration
Grant Categories: Agriculture Business and Commerce Education Employment Labor and Training Environment Health Natural Resources Regional Development Science and Technology
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-FD-11-006
Type of Funding: Cooperative Agreement
CFDA Numbers: 93.103
CFDA Descriptions: Food and Drug Administration_Research
Current Application Deadline: Jun 09, 2011
Original Application Deadline: Jun 09, 2011
Posted Date: Apr 21, 2011
Creation Date: Apr 21, 2011
Archive Date: Jul 09, 2011
Total Program Funding: $1,000,000
Maximum Federal Grant Award: $1,000,000
Minimum Federal Grant Award: $1,000,000
Expected Number of Awards: 1
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Public and State controlled institutions of higher education - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility
Addtionally Eligibilities Tribally Controlled College and Universities (TCCUs) Alaska Native and Native Hawaiian Serving Institutions Hispanic-serving Institutions Historically Black college and Universities (HBCUs)
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
Vieda HUBBARD Grants Management Specialist Phone 301-827-7177

vieda.hubbard@fda.hhs.gov [vieda.hubbard@fda.hhs.gov]
Similar Government Grants
FDA Scientific Conference Grant Program (R13)
Dissolution Methods for Semisolid Ocular Drug Products
Dissolution Methods for Microsphere and Implant Drug Products
Dissolution Methods for Suspension and Emulsion Ocular Drug Products
Quality by Design for Orally Inhaled Drugs: Chemistry, Manufacturing, and Controls (U01)
Support for Small Scientific Conference Grant Program
Cooperative Agreement to Support the World Health Organization (WHO) International Program...
Clinical Studies of Safety and Effectiveness of Orphan Products
More Grants from the Food and Drug Administration
FDA Scientific Conference Grant Program (R13)
Dissolution Methods for Semisolid Ocular Drug Products
Dissolution Methods for Microsphere and Implant Drug Products

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2016 FederalGrants.com